Oruka Therapeutics, Inc.
ORKA
37 insider filings · Latest: Aug 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aug 14 9:52 PM | Paul T QuinlanGeneral Counsel | Sale | 52,000 | $108.49 | $5.6M | 31,034(D) | View → |
| Aug 13, 2026 | Aug 14 9:42 PM | Arjun AgarwalSenior Vice President, Finance | Sale | 10,000 | $106.66 | $1.1M | 15,312(D) | View → |
| Aug 14, 2026 | Aug 14 8:39 PM | PAUL QUINLAN | Proposed Sale | 71,000 | $108.12 | $7.7M | — | View → |
| Jul 15, 2026 | Jul 15 11:36 PM | Joana GoncalvesChief Medical Officer | Sale | 7,000 | $86.28 | $603.9K | 32,718(D) | View → |
| Jul 15, 2026 | Jul 15 8:31 PM | JOANA GONCALVES | Proposed Sale | 21,000 | $87.47 | $1.8M | — | View → |
| Jul 13, 2026 | Jul 13 9:09 PM | Arjun AgarwalSenior Vice President, Finance | Sale | 9,999 | $84.63 | $846.2K | 15,312(D) | View → |
| Jul 13, 2026 | Jul 13 8:36 PM | Arjun Agarwal | Proposed Sale | 28,588 | $86.79 | $2.5M | — | View → |
| Jul 1, 2026 | Jul 2 1:31 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 3,553,410 | $84.43 | $300.0M | — | View → |
| Jul 1, 2026 | Jul 2 1:30 AM | Fairmount Funds Management LLCDirector, 10% Owner | Sale | 3,553,410 | $84.43 | $300.0M | 1,131,954(I) | View → |
| Jul 1, 2026 | Jul 1 11:58 PM | Laura Lee SandlerChief Operating Officer | Sale | 5,000 | $94.42 | $472.1K | 236,384(D) | View → |
| Jun 22, 2026 | Jun 22 11:59 PM | Arjun AgarwalSenior Vice President, Finance | Sale | 1,587 | $80.95 | $128.5K | 15,312(D) | View → |
| Jun 15, 2026 | Jun 15 10:57 PM | Arjun AgarwalSenior Vice President, Finance | Sale | 395 | $69.69 | $27.5K | 16,899(D) | View → |
| Jun 12, 2026 | Jun 15 10:57 PM | Arjun AgarwalSenior Vice President, Finance | Sale | 9,459 | $69.72 | $659.5K | 17,294(D) | View → |
| Jun 15, 2026 | Jun 15 10:54 PM | Joana GoncalvesChief Medical Officer | Sale | 7,947 | $69.28 | $550.6K | 32,718(D) | View → |
| Jun 15, 2026 | Jun 15 10:52 PM | Lawrence Otto KleinDirector, Chief Executive Officer | Sale | 1,729 | $69.69 | $120.5K | 925,580(D) | View → |
| Jun 15, 2026 | Jun 15 10:51 PM | Laura Lee SandlerChief Operating Officer | Sale | 600 | $69.69 | $41.8K | 236,384(D) | View → |
| Jun 15, 2026 | Jun 15 10:50 PM | Paul T QuinlanGeneral Counsel | Sale | 733 | $69.69 | $51.1K | 31,034(D) | View → |
| Jun 12, 2026 | Jun 12 8:36 PM | Carl DambkowskiDirector | Sale | 12,583 | $70.11 | $882.2K | 38,743(D) | View → |
| Jun 11, 2026 | Jun 12 8:36 PM | Carl DambkowskiDirector | Sale | 22,417 | $70.13 | $1.6M | 51,326(D) | View → |
| Jun 11, 2026 | Jun 11 8:24 PM | CARL DAMBKOWSKI | Proposed Sale | 35,000 | $64.03 | $2.2M | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 17 10:24 PM | Joana GoncalvesChief Medical Officer | Option Exercise | 7,000 | $7.80 | 189,492(D) | View → |
| Jan 23, 2026 | Jan 23 10:40 PM | Joana GoncalvesChief Medical Officer | Grant/Award | 130,000 | $34.39 | 130,000(D) | View → |
| Jan 23, 2026 | Jan 23 10:40 PM | Laura Lee SandlerChief Operating Officer | Grant/Award | 130,000 | $34.39 | 130,000(D) | View → |
| Jan 23, 2026 | Jan 23 10:40 PM | Arjun AgarwalSVP, Finance | Grant/Award | 70,000 | $34.39 | 70,000(D) | View → |
| Jan 23, 2026 | Jan 23 10:38 PM | Lawrence Otto KleinDirector, Chief Executive Officer | Grant/Award | 306,700 | $34.39 | 306,700(D) | View → |
| Jan 23, 2026 | Jan 23 10:36 PM | Paul T QuinlanGeneral Counsel | Grant/Award | 130,000 | $34.39 | 130,000(D) | View → |
| Jan 15, 2026 | Jan 16 10:26 PM | Joana GoncalvesChief Medical Officer | Option Exercise | 7,000 | $7.80 | 192,992(D) | View → |
← Previous
Page 2 of 2